Abbott: Xience V is better than Taxus, too

September 21, 2009 By MassDevice staff

Abbott threw another grenade Boston Scientific‘s way with a study showing its Xience V drug-eluting stent outperforms BoSci’s Taxus.

The news follows a Medtronic study that company touted earlier today, showing that its Endeavor stent is safer than the Taxus.

Chicago-based Abbott is touting its Spirit III trial comparing the Xience V everolimus-eluting coronary stent with BSX’s Taxus Express paclitaxel-eluting stent. In a study of 1,002 patients three years after being implanted with the stents, those with the Abbott product showed a 43 percent reduction in the risk of major adverse cardiac events compared with patients implanted with the Taxus Express device.

As of about 3:40 p.m. Sept. 21, Abbott shares were up 1.2 percent, to $46.32; Medtronic shares were flat at $37.45 ; and Boston Scientific shares were up just less than 1 percent at $11.06.

DTW Podcast: Vizient on PPE, Vicarious on VR-aided robotics and let’s all hope for pumpernickel
This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical. Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He’ll also reveal when the company expects to see US hospitals running at pre-Covid… […]
Are You GLP/GMP Compliant When it Comes to pipetting?
Are you following methods for current Good Laboratory Practice (cGLP) or current Good Manufacturing Practice (cGMP)? Quality systems and standards regulating product development and manufacturing of pharmaceuticals, medical devices, and the way clinical studies are conducted, such as GLP, GMP and ISO 9000 series, require that appropriate and technically valid standard operating procedures (SOPs) are… […]
How plasma treatment offers green, cost-efficient preparation of plastics
Surface treatment to prepare medical device components for printing or bonding may require complex cleaning methods or harmful chemicals. Plasma etching for improved adhesion, once limited to low-pressure chambers, is now available at atmospheric pressure. Erhard Krampe, Plasmatreat Conventional methods of surface preparation, treatment and modification of medical devices made of PTFE, FEP and polyamide are… […]
How much UV-C do you need for disinfection?
The idea of using UV-C light to kill the COVID-19 virus by disrupting its RNA has captured the imagination of many in the technical community. Unfortunately, important application details about factors such as necessary exposure time and intensity levels may be hard to discern, particularly for those who are new to the technology. A complicating… […]
Vietnam’s Vingroup to supply ventilator parts to Medtronic
When Medtronic (NYSE:MDT) announced in April that it had tapped Foxconn to manufacture ventilators at the Chinese company’s Wisconsin plant, then-Medtronic CEO Omar Ishrak said that Medtronic is also working with “major players” in Asia to expedite ventilator production. This week, Vietnam’s largest conglomerate, Vingroup, announced that it had inked a deal for two of its… […]
MedCrypt acquires MedISAO in medtech cybersecurity deal
Healthcare cybersecurity company MedCrypt (San Diego) today announced the acquisition of Irvine, Calif.-based MedISAO, a cybersecurity information-sharing organization that works with the medical device industry. MedCrypt is now offering MedISAO’s information-sharing analysis network for small and midsize business as well as its Cyber Protek software bill of materials (SBoM) and dependency vulnerability management tool. MedISAO’s… […]
The top digital health startups in the world
About two-fifths of the startups in CB Insights’ second annual Digital Health 150 list are engaged in telehealth, a high-demand area amid the COVID-19 pandemic. That is one of the big takeaways from the list of 150 promising digital health startups that CB Insights released today. CB Insights’ research team picked the 150 startups after… […]
Report: BD, Quidel struggle to supply antigen tests for COVID-19
Becton Dickinson (NYSE:BDX) and Quidel are struggling to fulfill orders for rapid COVID-19 antigen tests as the virus continues to spread, according to a report in the Wall Street Journal. The newspaper reported today that the two companies, which are the only ones that have FDA emergency use authorizations to sell the rapid diagnostics, cannot keep… […]
Nortech Systems closing one plant, selling two others
Nortech Systems (NSDQ:NSYS) announced this week that it will shutter one manufacturing plant and sell two others to lease them back following a tough year for the business. Maple Grove, Minn.-based Nortech said Tuesday that it will close its plant in Merrifield, Minn., by December 31, 2020, and offer that plant’s 60 employees jobs at its… […]
CMS proposes coverage updates that could increase access to VADs
The Centers for Medicare & Medicaid Services (CMS) today proposed coverage policy updates meant to increase access to VADs and artificial hearts. The policy updates, if approved, could be good news for major VAD makers Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) — as well as people with heart failure who are waiting for a heart transplant or don’t… […]
Exceeding regulatory requirements: Beyond the checklist
Many manufacturers run into issues as they adjust their devices and testing plans to meet updated regulatory requirements. Using a risk-based approach to predict and mitigate risks can help prevent costly setbacks. Sherry Parker, WuXi AppTec Between the EU Medical Device Regulation (MDR) delay and other regulatory bodies shifting priorities due to COVID-19, manufacturers are… […]